Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PCC Metals Group is an internal business unit of Precision Castparts Corp., itself owned by Berkshire Hathaway since January 2016. It comprises two leading metal/alloy companies—Special Metals Corporation (nickel-based superalloys) and Titanium Metals Corporation/TIMET (titanium products)—serving global aerospace, energy generation/power plant equipment manufacturers with advanced materials solutions. While some alloys may be used downstream in medical devices or healthcare equipment due to their properties, the group itself does not operate as a life science/biotech/pharma/CDMO/CRO entity nor develop drugs or therapeutics of any kind. Its core expertise lies in metallurgical innovation and large-scale industrial manufacturing rather than health-related R&D pipelines or clinical programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PCC Metals Group.